Influenza Management: Reviewing the Safety and Efficacy of Therapy Options
0290-0000-20-097-H01-P
This activity will provide an overview of influenza as well as a review of the goals of treatment and each of the therapies used in the management of influenza.
1.50
Treating Chronic Inflammatory Demyelinating Polyneuropathy With Immunoglobulin: Strategies for Appropriate Use and Accurate Dosing
0290-0000-20-095-L01-P
This live virtual symposium will examine the pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP).
6-16-2020
1.00
Integrating New and Emerging Treatment Options Into Therapy to Meet Unmet Needs in Schizophrenia
0290-0000-20-078-L01-P
This live activity will review the current treatment landscape of schizophrenia as well as evidence for novel therapies that have the potential to improve symptom management, optimize adherence, and reduce adverse effects.
4-27-2020
1.50
Examining the Use of Immunoglobulin for Primary Immunodeficiency Disorders
0290-0000-20-077-H01-P
This activity will prepare pharmacists to make determinations about patient eligibility for subcutaneous or intravenous IG administration, considerations for switching, and educate them about appropriate stewardship of IG products to optimize outcomes for patients with PIDs.
2.00